Mylan N.V. (NASDAQ: MYL) is -22.89% lower on its value in year-to-date trading and has touched a low of $12.75 and a high of $23.11 in the current 52-week trading range. The MYL stock was last observed hovering at around $16.38 in the last trading session, with the day’s loss setting it -0.88% off its average median price target of $20.50 for the next 12 months. It is also 46.55% off the consensus price target high of $29.00 offered by 16 analysts, but current levels are 8.82% higher than the price target low of $17.00 for the same period.
Currently trading at $15.50, the stock is -4.98% and -4.90% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.44 million and changing -5.37% at the moment leaves the stock -11.68% off its SMA200. MYL registered -19.56% loss for a year compared to 6-month loss of -7.90%. The firm has a 50-day simple moving average (SMA 50) of $16.37 and a 200-day simple moving average (SMA200) of $16.38.
The stock witnessed a -5.26% gain in the last 1 month and extending the period to 3 months gives it a -11.63%, and is -3.31% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.19% over the week and 3.49% over the month.
Mylan N.V. (MYL) has around 35000 employees, a market worth around $7.99B and $11.50B in sales. Current P/E ratio is 29.58 and Fwd P/E is 3.31. Profit margin for the company is 2.40%. Distance from 52-week low is 21.57% and -32.93% from its 52-week high. The company has generated returns on investments over the last 12 months (2.30%).
Mylan N.V. (MYL) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Mylan N.V. (MYL) is a “Overweight”. 16 analysts offering their recommendations for the stock have an average rating of 2.30, where 8 rate it as a Hold and 1 think it is a “Overweight”. 7 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Mylan N.V. is expected to release its quarterly report on 11/09/2020 and quarterly earnings per share for the current quarter are estimated at $1.17 with sales reaching $2.99B over the same period.The EPS is expected to shrink by -95.00% this year, but quarterly earnings will post 1.10% year-over-year. Quarterly sales are estimated to grow 0.90% in year-over-year returns.
Mylan N.V. (MYL) Top Institutional Holders
741 institutions hold shares in Mylan N.V. (MYL), with 7.11M shares held by insiders accounting for 1.37% while institutional investors hold 89.19% of the company’s shares. The shares outstanding are 516.90M, and float is at 510.93M with Short Float at 7.17%. Institutions hold 87.96% of the Float.
The top institutional shareholder in the company is Wellington Management Company, LLP with over 58.09 million shares valued at $934.04 million. The investor’s holdings represent 11.24% of the MYL Shares outstanding. As of Jun 29, 2020, the second largest holder is Vanguard Group, Inc. (The) with 57.34 million shares valued at $922.08 million to account for 11.09% of the shares outstanding. The other top investors are Blackrock Inc. which holds 43.95 million shares representing 8.50% and valued at over $706.79 million, while State Street Corporation holds 4.69% of the shares totaling 24.24 million with a market value of $389.74 million.
Mylan N.V. (MYL) Insider Activity
A total of 64 insider transactions have happened at Mylan N.V. (MYL) in the last six months, with sales accounting for 30 and purchases happening 34 times. The most recent transaction is an insider purchase by PARRISH MARK W, the company’s Director. SEC filings show that PARRISH MARK W bought 12,500 shares of the company’s common stock on Aug 11 at a price of $16.79 per share for a total of $0.21 million. Following the purchase, the insider now owns 58295.0 shares.
Mylan N.V. disclosed in a document filed with the SEC on Feb 05 that Campbell Paul sold a total of 11,611 shares of the company’s common stock. The trade occurred on Feb 05 and was made at $23.00 per share for $0.27 million. Following the transaction, the insider now directly holds 25413.0 shares of the MYL stock.
Mylan N.V. (MYL): Who are the competitors?
The company’s main competitors (and peers) include Sanofi (SNY) that is trading 12.48% up over the past 12 months. Lannett Company Inc. (LCI) is -49.85% down on the 1-year trading charts. Short interest in the company’s stock has risen 12.58% from the last report on Jul 14, 2020 to stand at a total of 32.04 million short shares sold with a short interest ratio of 8.18.